Portfolio Lab

Braze, Inc.

  • Stock
  • Ticker BRZE
  • ISIN US10576N1028
  • Nasdaq

Technology · Software and IT services · USA

$46.28 +0.09%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Braze, Inc. since 11/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

BRZEGlobal equities (VT)

$10,000 grew to $4,956. Global equities (VT): $14,438.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −83.2% in 02/2026, measured from the peak in 11/2021. The old peak has not been reached again yet.

1-year return
+71.4%
5-year return p.a.
−13.2%
Return p.a. since 11/2021
−13.1%
Volatility p.a.
66.6%
Largest decline
−83.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end10/202401/202504/202507/202510/202501/202604/202607/2026
Income statement
Revenue152160162180191205211227
Gross profit106111111122128134139152
Operating income-33-22-40-39-38-28-28-18
EBITDA-30-19-38-36-35-17-21-15
Net income-28-17-36-28-36-32-27-19
Earnings per share-0.27-0.17-0.34-0.26-0.33-0.29-0.24-0.17
Balance sheet
Total assets8428718891,0231,0411,1141,0911,131
Liabilities384396415423439490508529
Equity458475474599602624582600
Cash61832318198124145167
Cash flow
Operating cash flow-1117247.021192824
Capital expenditure-1.9-1.1-0.2-2.6-1.9-4.8-0.1-1.2
Free cash flow-1316244.319152823

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +94.8%, weakest 2022 at −64.6%. 1 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
9 Sep 2026−$0.17
28 May 2026−$0.24
25 Mar 2026−$0.29
10 Dec 2025−$0.33
5 Sep 2025−$0.26
6 Jun 2025−$0.34
31 Mar 2025−$0.17
10 Dec 2024−$0.27
6 Sep 2024−$0.23
7 Jun 2024−$0.35
1 Apr 2024−$0.29
7 Dec 2023−$0.31

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.8bn
Market cap in trading currency
$5.26bn
Enterprise value
$5.09bn
P/E
–
P/S
6.30
P/B
8.76
EV/Sales
6.10
EV/EBITDA
–
Earnings yield
–
FCF yield
1.6%

Results (last four quarters)

Revenue
$834m
Gross profit
$553m
EBITDA
−$87.7m
Net income
−$113m
Earnings per share
−$1.03
Revenue per share
$7.34
Revenue growth
+26.2%
Earnings growth
–

Profitability

Gross margin
66.3%
Operating margin
-13.4%
Net margin
-13.6%
Return on equity
-18.9%
Return on assets
-10.0%

Balance sheet and cash flow

Cash
$167m
Cash per share
$1.47
Financial debt
–
Debt/equity %
–
Current ratio
1.27
Book value per share
$5.28
Operating cash flow
$92.7m
Free cash flow
$84.6m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
114m
Volume
4.59m
Avg. volume 3 months
4.87m
Relative volume
0.9

Price and technicals

Price
$46.28
1 day
+0.1%
52-week high
$46.64
52-week low
$15.79
Distance to 52-week high
−0.8%
Distance to 52-week low
+193.1%
Distance to 50-day line
+29.0%
Distance to 200-day line
+75.5%
RSI (14)
78
Volatility 1M
5.3%

Performance

1 week
−0.8%
1 month
+0.9%
3 months
+47.2%
6 months
+90.1%
YTD
+35.0%
1 year
+70.0%

Dates

Fiscal year end
31 Jan 2026
Most recent quarter
31 Jul 2026

Frequently asked questions

How has BRZE performed since 11/2021?

$10,000 grew to $4,956 by 20 Nov 2026, which is −13.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BRZE?

Volatility was 66.6% per year, measured on monthly returns. The largest decline from a peak was −83.2%, with the low in 02/2026.

How does BRZE compare with a broad equity ETF?

Over the same period Global equities (VT) returned +7.6% per year at 15.4% volatility, BRZE returned −13.1% at 66.6%. The correlation of monthly returns was 0.12; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Braze, Inc. (BRZE): Return and risk | Portfolio Lab